Organic Active Ingredients TRIZ Cases

Fucosylated oligosaccharides in infant formula prevent premature adiposity rebound, reducing excessive fat mass accumulation and obesity risk.

Baclofen dosing reduces anxiety and irritability in Down syndrome while minimizing side effects from antipsychotics.

Converting zoledronic acid to disodium salt overcomes low oral bioavailability, achieving sustained plasma levels for effective pain relief.

Segmented oxymorphone formulations reduce dosing frequency and adjust bioavailability parameters for patients with renal impairment.

A vibrating mesh nebuliser generates fine iloprost aerosol droplets for pulmonary delivery.

Cyanine dyes exploit Warburg effect hypoglycemia to selectively target and disrupt mitochondrial ATP production in cancer cells.

A spiroquinone derivative compound suppresses microglial activation and enzyme activities through oxidative cyclization.

A single-stranded nucleic acid molecule bonds stearic acid to its linker region for direct tissue delivery.

Alternating polyelectrolyte layers degrade sequentially to sustain protein release over 34 days without harsh solvents.

A three-stage process produces soluble polymer conjugates by quenching residual vinylsulfone linkers to prevent incomplete reactions.

Topical 4-OHA prodrug reduces breast tumor volume enabling breast-conserving surgery by inhibiting cell proliferation.

Low-dose prostacyclin infusions reverse endothelial damage to reduce organ failure and mortality in acute critically ill patients.

Composite enteric coating on PPI pellets prevents alcohol-induced dose dumping by resisting dissolution in ethanol, ensuring consistent drug absorption.

Segmenting treatment into distinct mechanisms reduces toxicity while maintaining efficacy against multiple myeloma.

Systematic structural parameter changes on the pyrimidine core enhance metabolic stability and receptor selectivity for treating viral infections.

Bile acid polymer carriers enhance oral bioavailability by protecting drugs from degradation and improving intestinal permeability.

Small molecule inhibitors disrupt the CBFβ-SMMHC fusion protein interaction to selectively target leukemia cells.

Modified liposomes bind to specific transporters to cross the blood-brain barrier, enabling targeted cannabinoid delivery for neurological disorders.

Specific polymorphic forms of methylthioninium chloride resolve storage stability and bioavailability issues through controlled hydration.

Replacing silver diamine fluoride, PDDAF arrests caries and remineralizes lesions without causing permanent black staining on teeth.

Conjugating glucagon to an Fc fragment via a non-peptide linker stabilizes the peptide, reducing blood glucose fluctuations during obesity therapy.

Low-energy mechanical stirring forms stable miniemulsions with reduced surfactant content for bioactive delivery.

Fused oxazepine amide structures provide selective SSTR4 agonism and metabolic stability, reducing off-target side effects in oral therapies.

An RF microwave heating unit generates a dielectric field between concave electrodes to achieve rapid, uniform heating of solid aerosol substrates.

AX-8 activates TRPM8 receptors to reduce cough frequency, addressing inadequate chronic cough treatments with limited efficacy.

HMSs and HMOs restore intestinal absorption by enriching bifidobacteria, addressing ineffective symptom management in non-infectious diarrhea.

A morphinan derivative acts as a kappa opioid receptor agonist to inhibit sphincter of Oddi contraction.

Composite oligonucleotides resolve uptake and stability trade-offs to enable reliable in vivo gene suppression.

Viral vectors deliver CRISPR/Cas9 components to hepatocytes, resolving precision challenges in genetic defect correction.

IRES activation bypasses exon skipping limitations for 5' DMD mutations, sustaining functional dystrophin expression without plateau effects.

4-Phenetylamino-7H-pyrrolo[2,3-d]pyrimidine derivatives act as therapeutic agents to prevent and treat acute neurogenic inflammation.

Biodegradable cationic lipids reduce toxicity while maintaining delivery efficiency for repeated gene therapy dosing.

Formula I compounds selectively reduce neurotoxic Aβ42 secretion while preserving shorter isoforms, addressing insufficient specificity in existing treatments.

Characterized polymorphic forms stabilize physical properties to overcome unpredictable bioavailability in hormone-sensitive cancer therapies.

Targeting human TRPM3 channels reduces CGRP and PACAP levels, treating migraines in patients unresponsive to standard therapies.

PEO reduces alginate viscosity during electrospinning, preventing premature gelation and bead formation while maintaining fiber strength.

Intermittent MALT-1 inhibitor dosing destabilizes regulatory T cells while preserving cytotoxic immune function.

A microfluidic mixing chamber cools biomolecule compositions to enhance homogeneity during therapeutic polynucleotide formulation.

Soluble CD80 molecules bind PD-L1 to reverse immune suppression and restore T cell activation in cancer patients unresponsive to antibody therapies.

Single-step emulsion mixing yields sub-5 μm microparticles, resolving the trade-off between manufacturing complexity and drug bioavailability.

An anthocyanin-negatively charged polysaccharide complex enhances stability and absorption of active ingredients.

Oral modified bacteria produce tomatidine and p53 protein to inhibit muscle atrophy in cancer cachexia.

Acidifying agents create a localized acidic microenvironment around compound I, improving dissolution rates and bioavailability for thrombosis treatment.

PLGA-based injectable depots bypass the gastrointestinal tract to eliminate bleeding risks while maintaining therapeutic efficacy.

Non-peripheral quaternary ammonium-modified zinc phthalocyanine acts as a photosensitizer with enhanced tissue penetration.

Small-molecule inhibitors bind the PAM-interacting domain of Cas9 to reduce off-target effects while maintaining on-target editing capability.

Mesoporous silica nanoparticles deliver immunomodulatory moieties to activate immune cells and eliminate tumors.

An ethanol and glycol co-solvent system controls nicotine volatility for deep lung deposition, reducing oropharyngeal irritation.

Specific heterocyclic compounds enhance anti-tumoral immunity by targeting adenosine receptors while managing drug development complexity.

Biotechnological chondroitin 6-sulphate reduces molecular weight through controlled depolymerization to enhance intestinal absorption and bioavailability.

Ascorbic acid reduces oxidized PQQ to yellow crystals with 0.04-0.20 mg/mL water solubility, avoiding toxic byproducts.

High-dose dexamethasone expands Natural Killer T cells to target solid tumors, reducing chemotherapy toxicity.

Intravenous cetirizine injection delivers rapid symptom relief for acute urticaria without sedative effects.

Proteolyzed Andrias davidianus cartilage yields an enzymatic extract that treats hyperuricemia while avoiding shark population decline.

5-adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide inhibits NO and PGE2 production.

Formula I linking groups resolve the trade-off between sequence specificity and nuclease resistance in antisense therapeutics.

Sodium benzoate inhibits D-amino acid oxidase to augment NMDA-mediated glutamatergic neurotransmission.

Segmented chromene compounds reduce beta-catenin accumulation to inhibit tumor cell proliferation.

Transcribing at elevated temperatures using thermostable RNA polymerase reduces double-stranded RNA contaminants, eliminating costly purification steps.

Segmented bifunctional compounds recruit IKZF1 and BRD4 to the CRL4^CRBN complex, achieving selective protein degradation while managing structural complexity.

Selective inhibition of the mutant KCNJ3 N83H channel addresses inherited bradyarrhythmia without requiring pacemaker implantation.

Bioadhesive films deliver epinephrine through oral mucosa, preventing saliva mixing and restoring blood perfusion during anaphylaxis.

Combining Southernwood extract with THPED activates endogenous lipid pathways to increase ceramide levels, addressing inadequate hydration in dry skin.

MetAP2 inhibitor increases sRAGE and adiponectin while decreasing thrombomodulin, addressing vascular inflammation in renal disease.

An LPAR2 inhibitor promotes differentiation of dental pulp stem cells into odontoblasts and osteoblasts.

Thienocyclic compounds block EP4 receptors to inhibit tumor growth while improving metabolic stability and selectivity over EP1 and EP2 pathways.

Annulated 2-amino-3-cyano thiophene compounds inhibit KRAS proteins to control cellular proliferation while optimizing metabolic stability and solubility.

Dynamic dose titration of oral testosterone undecanoate maintains serum levels between 425 and 970 ng/dL, improving patient compliance.

A pharmaceutical composition comprising high doses of glucocorticoids achieves systemic lymphodepletion.

Novel diphenazine compounds derived from Cystobasidium laryngis fungi overcome limited natural availability through semi-synthetic structural modifications.

Inhibiting the 3betaHSD1 N367T variant reduces dihydrotestosterone synthesis, overcoming resistance to androgen deprivation therapy.

Macrocyclic deaza-purinones derivatives modulate Toll-Like Receptor 7 activity to resolve selectivity and potency trade-offs in viral infection treatments.

A recrystallization process controls lurasidone particle size and form for injectable suspensions.

Combines anti-T cell antibodies with vascular endothelial growth factor inhibitors to enable safer tumor treatment protocols.

Combines NDRI, vitamin D3, and vitamin K2 to treat inflammatory diseases.

Stabilizing components prevent oxidation of cannabinoids in packaged formulations, maintaining purity under varying environmental conditions.

A green tea extract composition containing specific GCG and EGCG ratios enhances cognitive function through targeted biochemical interactions.

Targeting the IL-1R1 pathway in tumor-associated myeloid cells overcomes poor response to standard treatments for KRAS-mutant cancers.

Acetylation of myricetin improves in-vivo stability, resolving the contradiction between safety and efficacy.

Oral amino acid secretagogue composition replaces invasive injections by stimulating pituitary gland to increase serum human growth hormone levels.

Novel amino-acid anilide compounds modulate IL-17 signaling pathways.

A preservative-free brimonidine ophthalmic composition uses specific surfactants to match natural tear film surface tension.

Segmented freezing and temperature extraction of Chrysophyllum cainito fruit overcomes insufficient active ingredient yield from simple methods.

Fermented Bacillus Velezensis KMU01 supernatant suppresses fat accumulation and lowers blood cholesterol levels through gut microbiota modulation.

Optimized particle size distribution balances dense bottle cap filling with rapid liquid dispersion, preventing clumps and scattering.

Zanthoxylum extract modulates Period gene expression rhythms, synchronizing circadian cycles to prevent rhythm disruption and associated diseases.

Acetyl L-carnitine prevents painful peripheral neuropathy in type 2 diabetes, addressing the lack of known preventive treatments.

Vacuolin-1 targets focal adhesion disassembly to inhibit cancer metastasis, offering a low-toxicity treatment option for lung and breast cancers.

Siplizumab combined with cyclophosphamide induces regulatory T-cell tolerance, reducing chronic rejection and systemic immunosuppression side effects.

Selective heterocyclic inhibitors target overexpressed LSD1 in cancer stem cells to overcome resistance mechanisms inherent in conventional cytotoxic therapies.